Patient Seminar Program

 

Co chairs, Ate van der Zee, Immediate Past President, ESGO & Louise Bayne, CEO Ovacome UK, opening the ESGO Patient Seminar

 

Ate van der Zee, Immediate Past President, ESGO introducing gynaecological cancers.

 

John Butler, International Cancer Benchmarking Partnership, Gynaecological Oncology Fellow St Bartholomews and Royal Marsden Hospital, UK talking about the inequalities in survival of gynaecological cancers in Europe today.

 

Ate van der Zee, Immediate Past President, ESGO talking to ESGO Patient Seminar participants.

 

From left to right : Isabel Mortara, Executive Director, Kenes Associations Worldwide ; Ate van der Zee, Immediate Past President, ESGO ; Louise Bayne, CEO, Ovacome UK and Jan Geissler, CEO Patvocates and Co-Founder CML Advocates Network.

 

ESGO Patient Seminar Participants enjoying a coffee break.

 

Session speakers during the Q & A. From left to right: Flavia Bideri, ACTO onlus, Italy (Patient Participation in Research) ; Jalid Sehouli, Charité Universitätsmedizin Berlin, Germany (Current options and the ongoing future of clinical trials) ; Emma Elliot, National Forum of Gynaecological Oncology Nurses, UK (Multidisciplinary treatment in gynaecological cancer) and Frederic Amant, UZ Gasthuisberg/Katholieke Universiteit Leuven, Belgium (Innovation, target therapies and individualised medicine)

 

Louise Bayne, CEO Ovacome, UK, speaking about their leading initiatives in Ovarian cancer.

 

Doris Schmitt, PATH, Germany presenting the Patient-driven breast cancer tumour bank as a possible model for gynaecological cancers.

Paola Mosconi, Istituto di Ricerche Farmacologiche Mario Negri, Italy speaking about ‘From patient literacy to advocacy’.

 

From left to right: Isabel Mortara, Executive Director, Kenes Associations Worldwide ; Ate van der Zee, Immediate Past President, ESGO and Nicoletta Colombo, ESGO President.

 

Laura Jakovljevic, from Roche, a sponsor of the patient seminar, networking during the coffee break.

Karen Orloff Kaplan, CEO, Ovarian Cancer National Alliance, USA, networking during the coffee break.

Pam Ganju from Morphotek , a sponsor of the patient seminar, networking during the coffee break.

 

Paola Casali (right), Istituto Nazionale dei Tumori, Milan, Italy, gave a presentation in relation to the rare cancer perspective during the afternoon session.

 

Susanna Leto, from Novartis, a sponsor of the patient seminar and Jean Mossman, Roche enjoying a well deserved coffee.

 

Participants networking during the coffee break.

Nicoletta Colombo, ESGO President, closing the Patient Seminar and calling on patient groups to work together with ESGO to give more attention to gynaecological cancer in Europe.